Abstract: The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
Type:
Application
Filed:
June 20, 2006
Publication date:
September 9, 2010
Applicants:
INSTITUE PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE